Targeting apoptosis dysregulation in myeloid malignancies - The promise of a therapeutic revolution
{{output}}
In recent years, the therapeutic landscape of myeloid malignancies has been completely revolutionized by the introduction of several new drugs, targeting molecular alterations or pathways crucial for leukemia cells survival. Particularly, many agents targeting... ...
